Explore the potential of bacteriophages as a breakthrough therapy against bacterial infections amidst rising antibiotic ...

"Microgravity pushed evolution into corners of the phage we still don't fully understand" ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Antibiotics have long been the go-to treatment for various infections. Still, almost as soon as the treatment was discovered in 1945, widespread use led to the rise of a new problem: antibiotic ...

The fight against bacterial infections is becoming harder. Across hospitals, some illnesses no longer respond to standard drugs, and doctors are forced to rely on last-line treatments. As bacteria ...

Antibiotic resistance is one of the most pressing challenges to global public health as harmful microbes evolve to evade these medications. Now, researchers at University of California San Diego and ...

Using cryo-electron microscopy, researchers have investigated the structure of Bas63, a bacteriophage of the subfamily Ounavirinae and the Felixounavirus genus which targets Escherichia coli, to ...

A University of Otago – Ōtākou Whakaihu Waka-led study has produced a detailed blueprint of a bacteriophage, furthering their potential in the fight against drug-resistant bacteria. Lead author Dr ...